Dermata Therapeutics share price logo

Dermata Therapeutics

NASDAQ: DRMA

$1.12

-0.01

(-0.88%)

as on

Dermata Therapeutics Stock Performance

as on October 8, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $1.11
    $1.13
    downward going graph

    0.89%

    Downside

    0.89%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.95
    $5.18
    downward going graph

    15.10%

    Downside

    362.50%

    Upside

    downward going graph

Dermata Therapeutics share price movements today

Previous Close
$1.13
Open
$1.12
Volume
166.1K
Market Cap
$5.6M
Day's Low - High
$1.11 - $1.13
52 Week Low - High
$0.95 - $5.18

Dermata Therapeutics Historical Returns

1 Month Return
-10.4 %
3 Month Return
-20 %
1 Year Return
-76.57 %
3 Year Return
-99.22 %
5 Year Return
-99.99 %

Dermata Therapeutics Stock Fundamentals & Key Indicators

Check Dermata Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$5.6M

EPS (TTM)

-4.39

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.26

Industry PE ratio

-2.36

PEG Ratio

-0.00

EBITDA

-8.5M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-166.67%

Dermata Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Dermata Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$5.6M-99.99%-0.260.00%0.00%
Neutral$74.8B-35.56%-23.49-12.57%0.00%
StrongBuy$127.3B182.58%29.0086.04%0.00%
Buy$74.8B34.93%17.6484.86%0.50%

Stock Returns calculator for Dermata Therapeutics Stock including INR - Dollar returns

The Dermata Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Dermata Therapeutics investment value today

Current value as on today

₹25,548

Returns

-₹74,452

(-74.45%)

Returns from Dermata Therapeutics Stock

-₹76,569 (-76.57%)

Dollar Impact

₹2,117 (+2.12%)

Analyst Recommendation on Dermata Therapeutics Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Dermata Therapeutics. Average target price of $4

Dermata Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Dermata Therapeutics.

What analysts predicted

72%UPSIDE

Target Price

$4

Current Price

$1.12

Analyzed by

7 Analysts

Target

$4.00

Dermata Therapeutics target price $4, a slight upside of 72% compared to current price of $1.12. According to 7 analysts rating.

Indian Investors' Interest in Dermata Therapeutics Stock

Search interest for Dermata Therapeutics Stock has decreased by -77% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-77% versus previous 30 day period

Dermata Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-3
-2
-3
-3
-2
-1
-1
-1
-1
-3
EBITDA
-3
-2
-3
-3
-2
-1
-1
-1
-1
-2
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
-
-
-
-
-
-
-
-
-
-
Income Before Tax
-3
-2
-3
-3
-2
-1
-1
-1
-1
-2
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-3
-2
-3
-3
-2
-1
-1
-1
-1
-2
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Dermata Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
Gross Profit
0
0
-
-
-
-
-
Operating Income
-4
-3
-7
-9
-8
-12
-7
EBITDA
-4
-3
-7
-9
0
-12
-7
Interest Expense
0
0
0
-
-
-
-
Depreciation
0
0
-
-
8
-
-
Income Before Tax
-4
-3
-7
-9
-7
-12
-7
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-4
-3
-7
-9
-7
-12
-7
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Dermata Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-3
-2
-3
-3
-2
-1
-1
-1
-1
-2
Operating Cash Flow
-2
-2
-3
-2
-1
-2
-1
-1
-2
-2
Investing Cash Flow
-
-
-
-
-
-
-
-
-
0
Financing Cash Flow
-
2
4
0
8
0
0
4
1
0
Change in Cash
-2
0
1
-2
6
-3
-1
2
0
-2

Dermata Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-4
-3
-7
-9
-7
-12
-7
Operating Cash Flow
-3
-4
-5
-8
-6
-11
-7
Investing Cash Flow
-
-
-
-
-
-
-
Financing Cash Flow
4
2
15
4
7
6
12
Change in Cash
0
-1
10
-4
1
-4
4

Global Institutional Holdings in Dermata Therapeutics

Check out the Institutions with significant holdings in Dermata Therapeutics.

Funds
Holdings
Fidelity Concord Street Trust
0.56%

Dermata Therapeutics News & Key Events

  • img

    Today's Timeline - 30 December

    Tue, 11:24 AM

    -

    Dermata Therapeutics closes $12.4 million private placement, shares rise 10.2% in after-hours trading.

Insights on Dermata Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 89.1% return, outperforming this stock by 188.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 603.7% return, outperforming this stock by 680.3%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, DRMA stock has moved down by -76.6%

About Dermata Therapeutics

Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
OrganisationDermata Therapeutics
Headquarters3525 Del Mar Heights Road, San Diego, CA, 92130, US
IndustryBiotechnology
CEOGerald T. Proehl

Key Management of Dermata Therapeutics

Name

Title

Mr. Gerald T. Proehl

Founder, President, CEO & Chairman

Mr. David F. Hale

Co-Founder & Lead Independent Director

Ms. Kyri K. Van Hoose CPA, M.B.A.

Senior VP & CFO

Dr. Christopher J. Nardo M.P.H., Ph.D.

Senior VP & Chief Development Officer

Mr. Sean Proehl

Associate General Counsel

Ms. Kyra Peckaitis

Vice President of Marketing

Dr. Maria Bedoya Toro Munera M.B.A., Ph.D.

Senior Vice President of Regulatory Affairs & Quality Assurance

FAQs

What is Dermata Therapeutics share price today?

Dermata Therapeutics share price today is $1.12 as on at the close of the market. Dermata Therapeutics share today touched a day high of $1.13 and a low of $1.11.

What is the 52 week high and 52 week low for Dermata Therapeutics share?

Dermata Therapeutics share touched a 52 week high of $5.18 on and a 52 week low of $0.95 on . Dermata Therapeutics stock price today i.e. is closed at $1.12,which is 78.38% down from its 52 week high and 17.78% up from its 52 week low.

What is Dermata Therapeutics's market capitalisation today?

Dermata Therapeutics market capitalisation is $0.00T as on .

How to invest in Dermata Therapeutics Stock (DRMA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Dermata Therapeutics on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Dermata Therapeutics Stock (DRMA) from India?

Indian investors can start investing in Dermata Therapeutics (DRMA) shares with as little as ₹96.779998779297 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹967.80 in Dermata Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Dermata Therapeutics share’s latest price of $1.12 as on October 8, 2026 at 8:45 am IST, you will get 8.9286 shares of Dermata Therapeutics. Learn more about fractional shares .

What are the returns that Dermata Therapeutics has given to Indian investors in the last 5 years?

Dermata Therapeutics stock has given -99.99% share price returns and 28.18% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?